{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T11:38:06Z","timestamp":1775475486301,"version":"3.50.1"},"reference-count":75,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jni-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Neuroimmunology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/j.jneuroim.2014.09.009","type":"journal-article","created":{"date-parts":[[2014,9,21]],"date-time":"2014-09-21T21:37:20Z","timestamp":1411335440000},"page":"1-5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["The risk of ischemic stroke in major rheumatic disorders"],"prefix":"10.1016","volume":"277","author":[{"given":"R\u00e9za","family":"Behrouz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jneuroim.2014.09.009_bb0005","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1177\/000331970505600512","article-title":"Risk factors for recurrent thrombosis: prospective study of a cohort of Japanese systemic lupus erythematosus","volume":"56","author":"Akimoto","year":"2005","journal-title":"Angiology"},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0010","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1177\/1759720X10365301","article-title":"Risk factors for coronary heart disease in connective tissue diseases","volume":"2","author":"Al Husain","year":"2010","journal-title":"Ther. Adv. Musculoskelet. Dis."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0015","first-page":"493","article-title":"Cardiovascular risk factor screening in systemic lupus erythematosus","volume":"30","author":"Al-Herz","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0020","series-title":"The Merck Manual of Diagnosis and Therapy","first-page":"297","article-title":"Chapter 35: joint disorders","author":"Altman","year":"2011"},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0025","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/0002-9343(89)90335-5","article-title":"Cerebrovascular disease and antiphospholipid antibodies in systemic lupus erythematosus, lupus-like disease, and the primary antiphospholipid syndrome","volume":"86","author":"Asherson","year":"1989","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0030","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1002\/art.24092","article-title":"Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies","volume":"59","author":"Avi\u00f1a-Zubieta","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0035","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/art.33322","article-title":"Noncardiac vascular disease in rheumatoid arthritis: increase in venous thromboembolic events?","volume":"64","author":"Bacani","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0040","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1093\/eurheartj\/ehr421","article-title":"Cyclooxygenase-2 inhibitors and cardiovascular risk in a nation-wide cohort study after the withdrawal of rofecoxib","volume":"33","author":"B\u00e4ck","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0045","doi-asserted-by":"crossref","first-page":"3565","DOI":"10.1007\/s00296-011-2237-8","article-title":"Ankylosing spondylitis is characterized by an increased turnover of several different metalloproteinase-derived collagen species: a cross-sectional study","volume":"32","author":"Bay-Jensen","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0050","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1136\/ard.2010.130476","article-title":"EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: report of a task force of the EULAR standing committee for clinical affairs","volume":"69","author":"Bertsias","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0055","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1093\/rheumatology\/keh213","article-title":"Risk of coronary heart disease and stroke in a large British cohort of patients with systemic lupus erythematosus","volume":"43","author":"Bessant","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0060","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.3171\/FOC\/2008\/24\/1\/E2","article-title":"A review of the pathogenesis of ankylosing spondylitis","volume":"24","author":"Dakwar","year":"2008","journal-title":"Neurosurg. Focus."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0065","article-title":"Systemic inflammation and cardiovascular risk factors predict rapid progression of atherosclerosis in rheumatoid arthritis","author":"Del Rinc\u00f3n","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0070","article-title":"Increased burden of inflammation over time is associated with the extent of atherosclerotic plaques in patients with psoriatic arthritis","author":"Eder","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0075","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ejim.2011.06.006","article-title":"Extra-articular manifestations of ankylosing spondylitis: prevalence, characteristics and therapeutic implications","volume":"22","author":"El Maghraoui","year":"2011","journal-title":"Eur. J. Intern. Med."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0080","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3109\/14397595.2013.843752","article-title":"Effects of infliximab treatment in terms of cardiovascular risk and insulin resistance in ankylosing spondylitis patients","volume":"24","author":"Ersozlu Bozkirli","year":"2014","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0085","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1002\/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I","article-title":"Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus","volume":"44","author":"Esdaile","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0090","first-page":"182","article-title":"Hypertension and diabetes significantly enhance the risk of cardiovascular disease in patients with psoriatic arthritis","volume":"32","author":"Favarato","year":"2014","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0095","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/01.hdx.0000089834.97829.5e","article-title":"Valvular heart disease and systemic lupus erythematosus: therapeutic implications","volume":"5","author":"Fluture","year":"2003","journal-title":"Heart Dis."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0100","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1161\/01.STR.20.5.583","article-title":"Frequency, etiology, and prevention of stroke in patients with systemic lupus erythematosus","volume":"20","author":"Futrell","year":"1989","journal-title":"Stroke"},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0105","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jaad.2005.03.046","article-title":"Epidemiology of psoriatic arthritis in the population of the United States","volume":"53","author":"Gelfand","year":"2005","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0110","first-page":"913","article-title":"Correlation between insulin resistance and serum ghrelin in non-diabetic ankylosing spondylitis patients undergoing anti-TNF-\u03b1 therapy","volume":"31","author":"Genre","year":"2013","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0115","doi-asserted-by":"crossref","first-page":"839135","DOI":"10.1155\/2014\/839135","article-title":"Carotid intima media thickness as a marker of atherosclerosis in ankylosing spondylitis","volume":"2014","author":"Gupta","year":"2014","journal-title":"Int. J. Rheumatol."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0120","series-title":"The Merck Manual of Diagnosis and Therapy","first-page":"332","article-title":"Chapter 33: autoimmune rheumatic disorders","author":"Hajj-ali","year":"2011"},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0125","doi-asserted-by":"crossref","first-page":"322","DOI":"10.3899\/jrheum.110792","article-title":"Assessment of preclinical atherosclerosis in patients with ankylosing spondylitis","volume":"39","author":"Hamdi","year":"2012","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0130","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/01.CIR.93.8.1579","article-title":"Heart valve involvement (Libman\u2013Sacks endocarditis) in the antiphospholipid syndrome","volume":"93","author":"Hojnik","year":"1996","journal-title":"Circulation"},{"issue":"Suppl. 3","key":"10.1016\/j.jneuroim.2014.09.009_bb0135","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/jdv.12163","article-title":"Cardiovascular morbidity and mortality in psoriasis and psoriatic arthritis: a systematic literature review","volume":"27","author":"Horreau","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0140","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/rheumatology\/41.6.619","article-title":"The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation","volume":"41","author":"Jennekens","year":"2002","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0145","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/archinte.165.9.978","article-title":"Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case\u2013control study","volume":"165","author":"Johnsen","year":"2005","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0150","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00296-013-2912-z","article-title":"Increased risk of stroke among patients with ankylosing spondylitis: a population-based matched-cohort study","volume":"34","author":"Keller","year":"2014","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0155","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJM199504133321504","article-title":"The management of thrombosis in the antiphospholipid\u2013antibody syndrome","volume":"332","author":"Khamashta","year":"1995","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0160","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1161\/01.STR.21.11.1533","article-title":"Stroke in systemic lupus erythematosus","volume":"21","author":"Kitagawa","year":"1990","journal-title":"Stroke"},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0165","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s004150070123","article-title":"Granulomatous cerebral vasculitis in systemic lupus erythematosus during systemic remission of disease","volume":"247","author":"Koerner","year":"2000","journal-title":"J. Neurol."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0170","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.amjmed.2005.05.026","article-title":"Stroke subtypes among young patients with systemic lupus erythematosus","volume":"118","author":"Krishnan","year":"2005","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0175","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMra002974","article-title":"The antiphospholipid syndrome","volume":"346","author":"Levine","year":"2002","journal-title":"NEJM"},{"issue":"4","key":"10.1016\/j.jneuroim.2014.09.009_bb0180","doi-asserted-by":"crossref","first-page":"e94027","DOI":"10.1371\/journal.pone.0094027","article-title":"Increased risk of ischemic stroke in young patients with ankylosing spondylitis: a population-based longitudinal follow-up study","volume":"9","author":"Lin","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0185","doi-asserted-by":"crossref","first-page":"e1257","DOI":"10.1136\/bmj.e1257","article-title":"Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study","volume":"344","author":"Lindhardsen","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0190","article-title":"Non-steroidal anti-inflammatory drugs and risk of cardiovascular disease in patients with rheumatoid arthritis: a nationwide cohort study","author":"Lindhardsen","year":"2013","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0195","doi-asserted-by":"crossref","first-page":"682","DOI":"10.7326\/0003-4819-112-9-682","article-title":"Antiphospholipid antibodies: anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders. Prevalence and clinical significance","volume":"112","author":"Love","year":"1990","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0200","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jbspin.2010.05.001","article-title":"Spondyloarthropathies: an independent cardiovascular risk factor?","volume":"77","author":"Mathieu","year":"2010","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0205","first-page":"S124","article-title":"Comparison of cardiovascular risk in ankylosing spondylitis and rheumatoid arthritis","volume":"27","author":"McCarey","year":"2009","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0210","doi-asserted-by":"crossref","first-page":"e1001098","DOI":"10.1371\/journal.pmed.1001098","article-title":"Cardiovascular risk with non-steroidal anti-inflammatory drugs: systematic review of population-based controlled observational studies","volume":"8","author":"McGettigan","year":"2011","journal-title":"PLoS Med."},{"issue":"2","key":"10.1016\/j.jneuroim.2014.09.009_bb0215","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/01.STR.0000254476.05620.14","article-title":"Baseline disease activity, hyperlipidemia, and hypertension are predictive factors for ischemic stroke and stroke severity in systemic lupus erythematosus","volume":"38","author":"Mikdashi","year":"2007","journal-title":"Stroke."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0220","first-page":"850","article-title":"TNF-alpha antagonist therapy improves insulin sensitivity in non-diabetic ankylosing spondylitis patients","volume":"30","author":"Miranda-Filloy","year":"2012","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0225","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.amjmed.2007.01.024","article-title":"Libman\u2013Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution","volume":"120","author":"Moyssakis","year":"2007","journal-title":"Am. J. Med."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0230","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1002\/art.27425","article-title":"Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955\u20132007","volume":"62","author":"Myasoedova","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0235","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/art.23935","article-title":"Cardiovascular, rheumatologic, and pharmacologic predictors of stroke in patients with rheumatoid arthritis: a nested, case\u2013control study","volume":"59","author":"Nadareishvili","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0240","doi-asserted-by":"crossref","first-page":"R30","DOI":"10.1186\/ar2383","article-title":"Cardiovascular disease in patients with rheumatoid arthritis: results from the QUEST-RA study","volume":"10","author":"Naranjo","year":"2008","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0245","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1177\/0961203313493031","article-title":"Premature atherosclerosis in systemic lupus erythematosus","volume":"22","author":"Nikpour","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0250","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11926-012-0270-6","article-title":"Cardiovascular and cerebrovascular diseases in ankylosing spondylitis: current insights","volume":"14","author":"Nurmohamed","year":"2012","journal-title":"Curr. Rheumatol. Rep."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0255","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1016\/j.amjcard.2005.02.010","article-title":"Valvular heart disease as a cause of cerebrovascular disease in patients with systemic lupus erythematosus","volume":"95","author":"Roldan","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0260","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.jcmg.2013.04.012","article-title":"Libman\u2013Sacks endocarditis and embolic cerebrovascular disease","volume":"6","author":"Roldan","year":"2013","journal-title":"JACC Cardiovasc. Imaging"},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0265","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/0961203306071872","article-title":"Effect of antimalarials on thrombosis and survival in patients with systemic lupus erythematosus","volume":"15","author":"Ruiz-Irastorza","year":"2006","journal-title":"Lupus"},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0270","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1002\/art.23109","article-title":"A systematic review of secondary thromboprophylaxis in patients with antiphospholipid antibodies","volume":"57","author":"Ruiz-Irastorza","year":"2007","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0275","first-page":"123","article-title":"Prevalence and prognosis of cerebrovascular accidents and its subtypes among patients with systemic lupus erythematosus in Isfahan, Iran: a hospital clinic-based study","volume":"5","author":"Saadatnia","year":"2014","journal-title":"Int. J. Prev. Med."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0280","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.berh.2006.02.001","article-title":"Concepts and epidemiology of spondyloarthritis","volume":"20","author":"Sieper","year":"2006","journal-title":"Best Pract. Res. Clin. Rheumatol."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0285","first-page":"641","article-title":"Increased incidence of stroke and impaired prognosis after stroke among patients with seropositive rheumatoid arthritis","volume":"27","author":"S\u00f6dergren","year":"2009","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0290","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/qjmed\/hcl005","article-title":"Neurological involvement in patients with rheumatic disease","volume":"99","author":"Sofat","year":"2006","journal-title":"QJM"},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0295","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1136\/ard.2005.050377","article-title":"Patterns of cardiovascular risk in rheumatoid arthritis","volume":"65","author":"Solomon","year":"2006","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0300","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1002\/art.30581","article-title":"Increased risk of cardiovascular and cerebrovascular diseases in individuals with ankylosing spondylitis: a population-based study","volume":"63","author":"Szabo","year":"2011","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0305","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/art.24014","article-title":"Subclinical carotid atherosclerosis in patients with psoriatic arthritis","volume":"59","author":"Tam","year":"2008","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0310","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/rheumatology\/ken090","article-title":"Cardiovascular risk profile of patients with psoriatic arthritis compared to controls\u2014the role of inflammation","volume":"47","author":"Tam","year":"2008","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0315","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1177\/0961203313497416","article-title":"Transient ischemic attack and stroke in systemic lupus erythematosus","volume":"22","author":"Timlin","year":"2013","journal-title":"Lupus"},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0320","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/00002281-200405000-00007","article-title":"Management of extra-articular disease manifestations in rheumatoid arthritis","volume":"16","author":"Turesson","year":"2004","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0325","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.amjcard.2005.04.022","article-title":"Five-year follow-up by transesophageal echocardiographic studies in primary antiphospholipid syndrome","volume":"96","author":"Turiel","year":"2005","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0330","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1161\/ATVBAHA.109.198424","article-title":"Rheumatic disease and carotid intima-media thickness: a systematic review and meta-analysis","volume":"30","author":"Tyrrell","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0335","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/pds.2227","article-title":"Stroke risk and NSAIDs: a systematic review of observational studies","volume":"20","author":"Varas-Lorenzo","year":"2011","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0340","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1136\/ard.2003.007740","article-title":"Endothelial dysfunction in young patients with rheumatoid arthritis and low disease activity","volume":"63","author":"Vaudo","year":"2004","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0345","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/1529-0131(199902)42:2<338::AID-ANR17>3.0.CO;2-U","article-title":"Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus","volume":"42","author":"Ward","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/RHU.0000000000000053","article-title":"Effect of golimumab on carotid atherosclerotic disease measures and cardiovascular events in inflammatory arthritides","volume":"20","author":"Wasko","year":"2014","journal-title":"J. Clin. Rheumatol."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0355","doi-asserted-by":"crossref","first-page":"361","DOI":"10.3899\/jrheum.080691","article-title":"Time trends in epidemiology and characteristics of psoriatic arthritis over 3 decades: a population-based study","volume":"36","author":"Wilson","year":"2009","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0360","first-page":"38","article-title":"Prevalence and clinical associations of lupus anticoagulant, anticardiolipin antibodies, and anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus","volume":"30","author":"Woo","year":"2010","journal-title":"Korean J. Lab. Med."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0365","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2165\/00128071-200304070-00001","article-title":"Prevalence of joint disease in patients with psoriasis: implications for therapy","volume":"4","author":"Zachariae","year":"2003","journal-title":"Am. J. Clin. Dermatol."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0370","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1136\/annrheumdis-2013-204715","article-title":"The association between inflammatory markers, serum lipids and the risk of cardiovascular events in patients with rheumatoid arthritis","volume":"73","author":"Zhang","year":"2014","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.jneuroim.2014.09.009_bb0375","doi-asserted-by":"crossref","first-page":"714321","DOI":"10.1155\/2012\/714321","article-title":"Cardiovascular risk in patients with psoriatic arthritis","volume":"2012","author":"Zhu","year":"2012","journal-title":"Int. J. Rheumatol."}],"container-title":["Journal of Neuroimmunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572814008868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165572814008868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T08:24:51Z","timestamp":1759047891000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165572814008868"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12]]},"references-count":75,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S0165572814008868"],"URL":"https:\/\/doi.org\/10.1016\/j.jneuroim.2014.09.009","relation":{},"ISSN":["0165-5728"],"issn-type":[{"value":"0165-5728","type":"print"}],"subject":[],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The risk of ischemic stroke in major rheumatic disorders","name":"articletitle","label":"Article Title"},{"value":"Journal of Neuroimmunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jneuroim.2014.09.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}